john herr psychologist los gatos saratoga california

On Sabbatical

National Library of Medicine: IGM Full Record Screen

Help Log off IGM
Next Record Return to Results Return to Search Screen Previous Record

TITLE: Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
AUTHOR: Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
AUTHOR AFFILIATION: Department of Obstetrics and Gynecology, University of California Los Angeles School of Medicine, 90095-1740, USA.
SOURCE: Obstet Gynecol 1997 Nov;90(5):709-14
NLM CIT. ID: 98012114
ABSTRACT: OBJECTIVE: To evaluate the anxiolytic 3alpha-5alpha-reduced progesterone metabolite allopregnanolone in the luteal phase of the menstrual cycle in women with premenstrual syndrome (PMS) and controls. METHODS: Thirty-five women with prospectively documented PMS and 36 controls were evaluated. Serum progesterone and allopregnanolone levels were measured on days 19 and 26 of the cycle as determined by urinary LH detection kits. Analysis of variance and Student t tests were used to analyze the data. RESULTS: Allopregnanolone levels were significantly lower on day 26 in the PMS group than in controls (3.6 +/- 0.8 versus 7.5 +/- 1.3 ng/mL; P <.04). Significant differences in the ratio of the metabolite to progesterone also were noted, with a smaller ratio in the PMS subjects (0.9 +/- 0.3 versus 3.2 +/- 1.3 ng/mL; P < .05). There were no significant differences between the PMS and control groups with respect to serum progesterone levels. CONCLUSION: Subjects with PMS manifested lower levels of the anxiolytic metabolite allopregnanolone in the luteal phase when compared with controls. Diminished concentrations of allopregnanolone in women with PMS may lead to an inability to enhance gamma aminobutyric acid-mediated inhibition during states of altered central nervous system excitability, such as ovulation or physiologic or psychological stress. The lowered metabolite levels could contribute to the genesis of various mood symptoms of the disorder, such as anxiety, tension, and depression.
GABA Modulators/*BLOOD
Premenstrual Syndrome/*BLOOD/PSYCHOLOGY
Case-Control Studies
Follicular Phase/BLOOD
Luteal Phase/BLOOD
Prospective Studies
REGISTRY NUMBERS: 0 (Anti-Anxiety Agents)
0 (GABA Modulators)
128-20-1 (Pregnanolone)
4406-35-3 (pregnan-3-ol-20-one)
57-83-0 (Progesterone)

Help Log off IGM
Next Record Return to Results Return to Search Screen Previous Record

On Sabbatical!

When my office lease expired at the end of 2004, I decided to turn it into a "sabbatical" from my private practice. Many years ago, in my grandfather's 89th year of life, he told me, "John, it is important to smell the roses while you can still smell them." His life gave living a very good reputation. It is also true that the pursuit of that philosophy required my grandfather to to re-open his assay office/ore market in Wickenburg, Arizona as a 75-year-old because he had run a little short of retirement money. Thus, if blessed with his luck and health, I'll be back.. --jjh

Copyright 1998-2007  John J. Herr, Ph.D.                                   Please send comments to